IBD research history about IBD studies available

An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

Study start: January 2005

The purpose of this study is to evaluate the efficacy and safety of Inflabloc Cap (Dehydroepiandrosterone [DHEA]) in the treatment of patients with moderately active Crohn's disease.
Condition Intervention Phase
Crohn's Disease Drug: Dehydroepiandrosterone [DHEA] Phase II

Atilla Ertan, MD
Houston, Texas, 77030, United States
Recruiting
Inci Ertan, PhD
713-794-0001
ieertan@tmh.tmc.edu
Atilla Ertan, MD, Principal Investigator

For more information:
http://clinicaltrials.gov/ct/show/NCT00106314?order=8

Principle Investigator:
Atilla Ertan, MD

Study Coordinator:
Inci Ertan, PHD
713-794-0001
ieertan@tmh.tmc.edu
Fax: 713-793-7661

Site Address:
6560 Fannin Street
Suite 2208
Houston, Texas 77030 United States

http://www.ccfa.org/trials/?rm=display_trial¢er_id=1208&doAnchors=1